Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 Next >
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
Tickers BIIB IONS
Tags Guidance IONS General
From Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
Tickers ACRS AMRS IONS
Tags NASDAQ:AMRS,NASDAQ:ACRS,NASDAQ:IONS AMRS ACRS
From InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
Tickers AZN AZNCF IONS
Tags Health Care Biotech Large Cap
From Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
Tickers AZN IONS
Tags Market News AZN IONS
From Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
Tickers ALNY ARWR IONS MRNA
Tags Analyst Color ARWR Expert Ideas
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Analyst Ratings Market News IONS
From Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
Tickers AZN AZNCF BXRX IONS
Tags Market News AZNCF Benzinga
From Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
Tickers BIIB IONS
Tags News Briefs Biotech
From Benzinga
Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags Analyst Ratings Market News Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Tickers ADC AIZ ALLO ALNY
Tags ALNY ALLO FL
From Benzinga
Wall Street predicts approval for another ALS drug
Tickers AMLX BIIB IONS
Tags AMLX BIIB IONS
From MarketWatch
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
Tickers BIIB IONS
Tags Large Cap Biotech Health Care
From Benzinga
Ionis Pharmaceuticals's Earnings Outlook
Tickers IONS
Tags IONS Benzinga Market News
From Benzinga
Analyst Says Ionis' Additional Hereditary Angioedema Study Data Supports 'Highly Competitive Profile'
Tickers IONS
Tags Analyst Color Expert Ideas Reiteration
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags BZI/AAR IONS Benzinga
From Benzinga
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
Tickers ARKG EXAS IONS PACB
Tags disruptive technology channel biotech EXAS
From ETF Trends
The Latest Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags IONS BZI/AAR Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
Tickers ADPT AIMC AMV APPN
Tags STKS ZION INMD
From Benzinga
Ionis Pharmaceuticals Earnings Perspective: Return On Capital Employed
Tickers IONS
Tags IONS Benzinga Earnings
From Benzinga
Gene Deal Adds New Dimension to Biotech ETF SBIO
Tickers ALPS IONS SBIO
Tags SS&C ETF Building Blocks Channel IONS
From ETF Trends
4 Analysts Have This to Say About Ionis Pharmaceuticals
Tickers IONS
Tags BZI/AAR IONS Benzinga
From Benzinga
Phillips 66 To Rally 25%? Here Are 5 Other Price Target Changes For Thursday
Tickers HCAT IONS PSX RSKD
Tags PSX Markets HCAT
From Benzinga
Ionis Regains Rights To Thrombosis Candidate From Bayer
Tickers BAYRY BAYZF IONS
Tags Benzinga BAYZF BAYRY
From Benzinga
3 Biotech Stocks to Sell in October
Tickers GILD GLPG ILMN IONS
Tags GLPG IONS Stocks to Sell
From InvestorPlace
AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med
Tickers AZN AZNCF IONS
Tags why it's moving News Briefs
From Benzinga
This Stock Has Delivered a Gain of 100% Over the Past 3 Months. Can You Still Buy?
Tickers AMLX BIIB IONS
Tags IONS Recent Press Releases BIIB
From Motley Fool
There's 'Outsized' Risk-Reward For This Biotech, Morgan Stanley Says, Predicting Shares Could Grow More Than 30%
Tickers IONS
Tags IONS General Upgrades
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
Tickers ADCT ALEC ANNX ARVN
Tags PTCT AXL PRGS
From Benzinga
Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags Analyst Ratings Market News Benzinga
From Benzinga
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
Tickers BCYC DBVT ERAS GKOS
Tags ERAS VIRX News
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.